Exogenous administration of substance P enhances wound healing in a novel skin-injury model

Experimental Biology and Medicine

Volumn 230, Issue 4, 2005, Pages 271-280

  Delgado, Angel V ^a   McManus, Albert T ^a   Chambers, James P ^b  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

CO2 laser; Neurite outgrowth; Substance P; Wound healing

Indexed keywords

CELL ADHESION MOLECULE; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE; SUBSTANCE P;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM CELL; EPITHELIUM CELL; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; MALE; NERVE FIBER GROWTH; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; RAT; SKIN INFLAMMATION; SKIN INJURY; SOFT TISSUE INJURY; WOUND HEALING;

EID: 16444369890     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020523000407     Document Type: Article

References (51)

1. Payan DG, Goetzl EJ. Modulation of lymphocyte function by sensory neuropeptides. J Immunol 135(Suppl 2):783-786, 1985.
2. Li Y, Tian S, Douglas SD, Ho WZ. Morphine up-regulates expression of substance P and its receptor in human blood mononuclear phagocytes and lymphocytes. Cell Immunol 205:120-127, 2000.
3. Lai XN, Wang ZG, Zhu JM, Wang LL. Effect of substance P in gene expression of transforming growth factor beta-1 and its receptors in rat's fibroblasts. Chin J Traumatol 6:350-354, 2003.
4. Smith PG, Liu M. Impaired cutaneous wound healing after sensory denervation in developing rats: effects on cell proliferation and apoptosis. Cell Tissue Res 307:281-291 2002.
5. Ho WZ, Lai JP, Li Y, Douglas SD. HIV enhances substance P expression in human immune cells. FASEB J 16:616-618, 2002.
6. Jansco N, Jansco-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 31:131-151, 1967.
7. Ralevic V, Milner P, Hudlicka O, Kristek F, Burnstock G. Substance P is released from the endothelium of normal and capsaicin treated rat hind-limb vasculature in vivo, by increased flow. Circ Res 66:1178-1183, 1990.
8. Wallengren J, Hakanson R. Effects of substance P, neurokinin A and calcitonin gene-related peptide in human skin and their involvement in sensory nerve-mediated responses. Eur J Pharmacol 143:267-273, 1987.
9. Barnes PJ, Brown MJ, Dollery CT, Fuller RW, Heavey DJ, Ind PW. Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex. Br J Pharmacol 88:741-745, 1986.
10. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24:739-768, 1988.
11. Dunnick CA, Gibran NS, Heimbach DM. Substance P has a role in neurogenic mediation of human burn wound healing. J Bum Care Rehabil 17:390-396, 1996.
12. Bockers M, Benes P, Bork K. Persistent skin ulcers, mutilations and acro-osteolysis in hereditary sensory and autonomic neuropathy with phospholipid excretion. J Am Acad Dermatol 21:736-739, 1989.
13. Hagen NA, Stevens JC, Michel CJ. Trigeminal sensory neuropathy associated with connective tissue disease. Neurology 40:891-896, 1990.
14. Ziehe M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi CA. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 40:264-278, 1990.
15. Namuri S, Fujita T. Stimulatory effects of substance P and nerve growth factor (NGF) on neurite outgrowth in embryonic chick dorsal root ganglia. Neuropharmacology 17:73-76, 1978.
16. Fan TP, Hu DE, Smither RL, Gresham GA. Further studies on angiogenesis in a rat sponge model. EXS 61:308-314, 1992.
17. Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol 110:43-49, 1993.
18. Nilsson J, von Euler AM, Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature 315:63-63, 1985.
19. Kahler CM, Reinisch N, Wiederman CJ. Interaction of SP with epidermal growth factor and fibroblast growth factor in cyclooxygenase-dependent proliferation of human skin fibroblasts. J Cell Physiol 166:601-608, 1996.
20. McGovern UB, Jones KT, Sharpe GR. Intracellular calcium as a second messenger following growth stimulation of human keratinocytes. Br J Dermatol 132:892-896, 1995.
21. Tanaka TT, Danno K, Ikai K, Imamura S. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 90:399-401, 1988.
22. Wollina U. The effect of neuropeptides on wound healing in vitro and in vivo. Hautarzt 43:616-620, 1992.
23. Zawacki BE, Jones RJ. Standard depth burns in the rat: the importance of the hair growth cycle. Br J Plast Surg 20:347-354, 1967.
24. McCarthy BG, Hsieh ST, Stocks A, Hauer P, Macko C, Cornblath DR, Griffin JW, McArthur JC. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 41:1848-1855, 1995.
25. Weisberg NK, Kuo T, Torkian B, Reinisch L, Ellis DL. Optimizing fluence and debridement effects on cutaneous resurfacing carbon dioxide laser surgery. Arch Dermatol 134:1223-1228, 1998.
26. 2 laser resurfacing. J Cosmet Laser Ther 3:123-127, 2001.
27. 2 surgical laser and conventional surgical techniques on healing and wound tensile strength of skin flaps in the dog. Vet Surg 32:153-160, 2003.
28. Domankevitz Y, Nishioka NS. Effects of a rapid scanned carbon dioxide laser on porcine dermis. J Burn Care Rehabil 18:206-209, 1997.
29. Pernow B. Substance P. Pharmacol Rev 35:85-141, 1983.
30. White DM. Release of substance P from peripheral sensory nerve terminals. J Peripher Nerv Syst 2:191-201, 1997.
31. Menkes CJ, Renoux M, Laoussadi S, Mauborgne J, Cesselin F. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 20:714-717, 1993.
32. Navarro X, Verdu E, Wendelschafer-Crabb G, Kennedy WR. Immunohistochemical study of skin reinnervation by regenerative axons. J Comp Neurol 380:164-174, 1997.
33. Altun V, Hakvoort TE, van Zuijlen PP, van der Kwast TH, Prens EP. Nerve outgrowth and neuropeptide expression during the remodeling of human burn wound scars: a 7-month follow-up study of 22 patients. Burns 27:717-722, 2001.
34. Gibran NS, Jang YC, Isik FF, Greenhalgh DG, Muffley LA, Underwood RA, Usui ML, Larsen J, Smith DG, Bunnett N, Ansel JC, Olerud JE. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 108:122-128, 2002.
35. Khalil Z, Helme R. Sensory peptides as neuromodulators of wound healing in aged rats. J Gerontol A Biol Sci Med Sci 51:B354-B361, 1996.
36. Bowles WR, Withrow JC, Lepinski AM, Hargreaves KM. Tissue levels of immunoreactive substance P are increased in patients with irreversible pulpitis. J Endod 29:265-267, 2003.
37. Buttow NC, Zucoloto S, Espreafico EM, Gama P, Alvares EP. Substance P enhances neuronal area and epithelial cell proliferation after colon denervation in rats. Dig Dis Sci 48:2069-2076, 2003.
38. Bowden JJ, Garland AM, Baluk P, Lefevre P, Grady EF, Vigna SR, Bunnett NW, McDonald DM. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci U S A 91:8964-8968, 1994.
39. King KA, Hu C, Rodriguez MM, Romaguera R, Jiang X, Piedimonte G. Exaggerated neurogenic inflammation and substance P receptor regulation in RSV-infected weanling rats. Am J Respir Cell Mol Biol 24:101-107, 2001.
40. Velazquez RA, McCarson KE, Cai Y, Kovacs KJ, Shi Q, Evensjo M, Larson AA. Upregulation of neurokinin-1 receptor expression in rat cord by an N-terminal metabolite of substance P. Eur J Neurosci 16:229-241, 2002.
41. Shi X, Gao NR, Guo QM, Yang YJ, Huo MD, Hu HL, Friess H. Relationship between overexpression of NK-1R, NK-2R and intestinal mucosal damage in acute necrotizing pancreatitis. World J Gastroenterol 9:160-164, 2003.
42. Weinstock JV, Blum A, Metwali A, Elliot D, Arsenescu R. IL-18 and IL-12 signal through the NK-kappa B pathway to induce NK-1R expression on T cells. J Immunol 170:5003-5007, 2003.
43. Lindner G, Grosse G, Jentzch KD, Oehme P, Wenzel M. Effect of derivatives of substance P dipeptide on nerve fiber growth in tissue culture. J Hirnforsch 27:639-649, 1986.
44. Narumi S, Fujita T. Stimulatory effects of substance P and nerve growth factor (NGF) on neurite outgrowth in embryonic chick dorsal root ganglia. Neuropharmacology 17:73-76, 1978.
45. Farhadieh RD, Nicklin S, Yu Y, Gianoutosos MP, Walsh WR. The role of nerve growth factor and brain-derived neurotrophic factor in inferior alveolar nerve regeneration in distraction osteogenesis. J Craniofac Surg 14:859-865, 2003.
46. Lee AC, Yu VM, Lowe JB, Brenner MJ, Hunter DA, Mackinnon SE, Sakiyama-Elbert SE. Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp Neurol 184:295-303, 2003.
47. Kahler CM, Pischel A, Kaufman G, Wiedermann CJ. Influence of neuropeptides on neutrophil adhesion and transmigration through a lung fibroblast barrier in vitro. Exp Lung Res 27:25-46, 2001.
48. Cao T, Grant AD, Gerard NP, Brain SD. Lack of significant effect of deletion of the tachykinin neurokinin-1 receptor on wound healing in mouse skin. Neuroscience 108:695-700, 2001.
49. Kuhn T, Schmidt M, Kater S. Laminin and fibronectin guidepost signal sustained but opposite effects to passing growth cones. Neuron 14:275-285, 1995.
50. Lefcort F, Venstrom K, McDonald JA, Reichardt LF. Regulation of the expression of fibronectin and its receptor α5β1, during developing and regeneration of peripheral nerve. Development 116:767-782, 1992.
51. Condic ML. Adult neuronal regeneration induced by transgenic integrin expression. J Neurosci 21:4782-4788, 2001.